This page lists all pharmaceutical reports related to the field of Neurodegenerative & Neuroelectrophysiological Disorders. The reports include market research reports and pipeline analyses.
Displaying 101 - 142 of 142 results
- Neurology Devices Market Outlook in Japan to 2016 - Neurostimulation Devices, Interventional Neurology and Others
- CNS Clinical Trials: World Market Prospects 2011-2026
- US Pharmaceutical Market Outlook 2011-2021
- Pharmaceutical Industry - 2010 Yearbook - Therapeutic Market Landscape, Key Pipeline Drugs, Top Pharma Companies and Key Mergers and Acquisitions
- Epidemiology: Parkinson's Disease
- Future Directions in Regenerative Medicine
- UpdatesPlus Nicotinic Receptors - Current Research and Development - March 2011
- Pharmaceutical Key Trends 2011 – Generics Market Overview: Patent cliff set to drive global generic uptake despite tougher market conditions
- Pharmaceutical Key Trends 2011 – Pharmaceutical Industry Infrastructure Overview: Pharma innovates, diversifies and contains cost in order to grow profits
- R&D Trends: Multiple Sclerosis (MS) - Progressive subtypes remain underserved in expansive pipeline
- UpdatesPlus Nicotinic Receptors and Addiction - Current Research and Development - April/May 2011
- Biotech M&A and Licensing Strategies - Co-development Agreements are Poised to Increase in the Future to Counter Drying Pipelines
- Top R&D Drug Failures - Toxicity and Serious Adverse Events in Late Stage Drug Development are the Major Causes of Drug Failure
- Comparative Analysis of Late Stage Pipeline Molecules in Major Indications - Oncology Pipeline Leads with Most Promising Molecules in Late Stage Development
- Anticonvulsants Market to 2016 - Cost Advantage and Dosage Convenience Provided by Generic Anticonvulsants Will Limit Commercial Opportunities for Novel Therapies
- Early Stage Drug Discovery in Disease Segments - Innovation Focuses on Stem Cell Therapies and Gene Therapies
- Preclinical Models - Preclinical CROs will Continue to Improve the Quality and Accuracy of Data for Targeted Therapies
- Biomarkers in Drug Discovery - Earlier Usage of Biomarkers in Optimization Stage to Reduce Drug Attrition Rate Significantly
- Neupro (Parkinson's Disease) - Analysis and Forecasts to 2020
- Eldepryl (Parkinson's Disease) – Analysis and Forecasts to 2012
- Azilect (Parkinson's Disease) – Analysis and Forecasts to 2020
- Neurodegenerative Disease Market to 2017 - Patent Expiries of High Selling Drugs Such as Aricept, Namenda, Avonex, Rebif and Copaxone will Restrain Growth
- Central Nervous System Disorders Therapeutics Market to 2017 - Multiple Sclerosis, Major Depressive Disorder and Schizophrenia Accounted for Half the Market Value in 2010
- GPCRs in Drug Discovery - Efforts to De-Orphanize Novel GPCR Targets are Increasing
- Neurology Devices Market to 2017 - High Potential for Usage of Neurostimulation Devices in Multiple Neurological Disorders to Drive Market Growth
- Apokyn (Parkinson's Disease) – Analysis and Forecasts to 2020
- Tasmar (Parkinson's Disease) – Analysis and Forecasts to 2020
- Stalevo (Parkinson's Disease) – Analysis and Forecasts to 2020
- Comtan (Parkinson's Disease) - Analysis and Forecasts to 2020
- KW-6002 (Parkinson's Disease) – Analysis and Forecasts to 2020
- IPX066 (Parkinson's Disease) – Analysis and Forecasts to 2020
- Trerief (Parkinson's Disease) – Analysis and Forecasts to 2020
- Requip XL (Parkinson's Disease) – Analysis and Forecasts to 2020
- Mirapex (Parkinson's Disease) – Analysis and Forecasts to 2020
- Mirapex ER (Parkinson's Disease) – Analysis and Forecasts to 2020
- Pardoprunox (Parkinson's Disease) – Analysis and Forecasts to 2020
- Preladenant (Parkinson's Disease) – Analysis and Forecasts to 2020
- Safinamide (Parkinson's Disease) – Analysis and Forecasts to 2020
- Zelapar (Parkinson's Disease) – Analysis and Forecasts to 2020
- Requip (Parkinson's Disease) – Analysis and Forecasts to 2020
- Acute Ischemic Stroke (AIS) Therapeutics - Pipeline Assessment and Market Forecasts to 2018
- Amyotrophic Lateral Sclerosis (ALS) Therapeutics - Pipeline Assessment and Market Forecasts to 2018